News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
261,776 Results
Type
Article (13948)
Company Profile (304)
Press Release (247524)
Section
Business (79361)
Career Advice (151)
Deals (13190)
Drug Delivery (34)
Drug Development (50336)
Employer Resources (31)
FDA (5685)
Job Trends (5116)
News (144151)
Policy (10020)
Tag
Academia (901)
Alliances (21528)
Alzheimer's disease (762)
Approvals (5665)
Artificial intelligence (68)
Bankruptcy (97)
Best Places to Work (4523)
Biotechnology (249)
Breast cancer (109)
Cancer (888)
Cardiovascular disease (71)
Career advice (132)
CAR-T (73)
Cell therapy (217)
Clinical research (40140)
Collaboration (308)
Compensation (128)
COVID-19 (1006)
C-suite (78)
Cystic fibrosis (66)
Data (983)
Diabetes (85)
Diagnostics (1207)
Drug discovery (56)
Earnings (29004)
Events (47208)
Executive appointments (248)
FDA (6052)
Funding (306)
Gene editing (63)
Gene therapy (163)
GLP-1 (310)
Government (1065)
Healthcare (6543)
Infectious disease (1043)
Inflammatory bowel disease (98)
IPO (7197)
Job creations (859)
Job search strategy (127)
Layoffs (188)
Legal (1375)
Lung cancer (130)
Lymphoma (62)
Manufacturing (86)
Medical device (2562)
Medtech (2563)
Mergers & acquisitions (6128)
Metabolic disorders (257)
Neuroscience (1006)
NextGen Class of 2024 (2004)
Non-profit (848)
Northern California (1092)
Obesity (140)
Opinion (91)
Parkinson's disease (75)
Patents (61)
People (25106)
Phase I (14153)
Phase II (18664)
Phase III (11818)
Pipeline (367)
Postmarket research (851)
Preclinical (5972)
Radiopharmaceuticals (205)
Rare diseases (201)
Real estate (1409)
Regulatory (8283)
Research institute (931)
Southern California (976)
Startups (1964)
United States (8656)
Vaccines (164)
Weight loss (83)
Date
Today (1)
Last 7 days (364)
Last 30 days (1427)
Last 365 days (20546)
2024 (20450)
2023 (22419)
2022 (26834)
2021 (27810)
2020 (23360)
2019 (16225)
2018 (11738)
2017 (13751)
2016 (11845)
2015 (14351)
2014 (10395)
2013 (7486)
2012 (7532)
2011 (7616)
2010 (7430)
Location
Africa (146)
Asia (16936)
Australia (2856)
California (2475)
Canada (811)
China (203)
Colorado (91)
Connecticut (103)
Europe (36453)
Florida (271)
Georgia (71)
Illinois (153)
Indiana (61)
Kansas (55)
Maryland (330)
Massachusetts (1955)
Minnesota (101)
New Jersey (630)
New York (682)
North Carolina (419)
Northern California (1092)
Ohio (82)
Pennsylvania (474)
South America (207)
Southern California (976)
Texas (278)
Washington State (247)
261,776 Results for "neurona therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
Neurona Therapeutics to Participate in Jefferies Global Healthcare Conference
Neurona Therapeutics, a clinical-stage biotherapeutics company focused on advancing regenerative cell therapies for the potential treatment of neurological disorders, today announced that Cory R. Nicholas, Ph.D., Neurona’s Co-Founder and Chief Executive Officer, is scheduled to host investor meetings at the Jefferies Global Healthcare Conference being held at the Marriott Marquis in New York, NY on June 4-6, 2024.
May 28, 2024
·
1 min read
Business
Neurona Therapeutics Appoints Dr. Manher Joshi as Chief Medical Officer
Neurona Therapeutics, a clinical-stage biotherapeutics company focused on advancing regenerative cell therapies for disorders of the nervous system, today announced the appointment of Manher (AJ) Joshi, M.D., as Chief Medical Officer.
June 11, 2024
·
3 min read
Business
Neurona Therapeutics Appoints Dr. Nadia Agopyan as Senior Vice President of Regulatory Affairs
Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapies for disorders of the nervous system, today announced the appointment of Nadia Agopyan, Ph.D., RAC, as Senior Vice President of Regulatory Affairs.
June 26, 2024
·
4 min read
News
Neurona Therapeutics Announces Participation in Upcoming Investor Conferences in October
September 27, 2024
·
1 min read
Biotech Bay
Neurona Therapeutics to Present at Stifel 2024 Virtual CNS Days
Neurona Therapeutics today announced that Cory R. Nicholas, Ph.D., Neurona’s chief executive officer, will present a corporate update on Tuesday, March 19 at 5:00 pm ET and host one-on-one meetings during the Stifel 2024 Virtual CNS Days taking place on March 19-20, 2024.
March 12, 2024
·
1 min read
Biotech Bay
Neurona Therapeutics Receives FDA’s Regenerative Medicine Advanced Therapy (RMAT) Designation for NRTX-1001 in Focal Epilepsy
Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapies for disorders of the nervous system, today announced that the U.S Food and Drug Administration (FDA) has granted the company’s lead product candidate, NRTX-1001, the RMAT expedited program designation for drug-resistant mesial temporal lobe epilepsy (MTLE).
June 18, 2024
·
5 min read
Press Releases
Neurona Therapeutics Presents Positive Clinical Update: New Data from NRTX-1001 Cell Therapy Trial in Drug-Resistant Epilepsy Announced at 2024 Annual Meeting of the American Epilepsy Society
December 9, 2024
·
6 min read
Biotech Bay
Neurona Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Lifesciences Conference
Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapy candidates for the treatment of neurological disorders, today announced that Cory R. Nicholas, Ph.D., Neurona’s chief executive officer, will provide a corporate update at the Oppenheimer 34th Annual Healthcare Lifesciences Conference on Wednesday, February 14 at 2:00 pm ET.
February 7, 2024
·
1 min read
Press Releases
Neurona Therapeutics Receives $3.8 Million CIRM Grant for the Development of Next Generation Neural Cell Therapy Candidate
September 11, 2024
·
3 min read
Biotech Bay
Neurona Therapeutics Raises $120M to Advance Groundbreaking Pipeline of Regenerative Cell Therapy Candidates for Chronic Neurological Disorders
Neurona Therapeutics today announced the successful completion of a $120 million financing co-led by Viking Global Investors and Cormorant Asset Management with participation from new and existing investors.
February 8, 2024
·
8 min read
1 of 26,178
Next
